Properties (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine manufacturer
|
| gptkbp:acquisition |
gptkb:Poonawalla_Group
|
| gptkbp:capacity |
1.5 billion doses per year
|
| gptkbp:certifications |
WHO prequalification
|
| gptkbp:clinicalTrials |
conducts vaccine trials
|
| gptkbp:collaborations |
gptkb:GAVI_Alliance
gptkb:Bill_&_Melinda_Gates_Foundation |
| gptkbp:employees |
over 5000
|
| gptkbp:exportedTo |
to over 170 countries
|
| gptkbp:founded |
1966
|
| gptkbp:founder |
gptkb:Cyrus_Poonawalla
|
| gptkbp:headquarters |
gptkb:Pune,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Serum Institute of India
|
| gptkbp:market |
largest vaccine producer in the world
|
| gptkbp:notableEvent |
Covishield
|
| gptkbp:partnerships |
gptkb:AstraZeneca
|
| gptkbp:productionCompany |
gptkb:Good_Manufacturing_Practices_(GMP)
|
| gptkbp:products |
vaccines
|
| gptkbp:researchAndDevelopment |
vaccine technology
|
| gptkbp:respondsTo |
produced vaccines
|
| gptkbp:revenue |
over $1 billion
|
| gptkbp:social_responsibility |
affordable vaccines
|